Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice

SIMPLE SUMMARY: A number of agents, including immune checkpoint inhibitors, have become available for the treatment of hepatocellular carcinoma, but the objective response rate of these drugs is currently only 30% to 40%. Therefore, the identification of new predictive biomarkers and an increased kn...

Descripción completa

Detalles Bibliográficos
Autores principales: Motomura, Kenta, Kuwano, Akifumi, Tanaka, Kosuke, Koga, Yuta, Masumoto, Akihide, Yada, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486942/
https://www.ncbi.nlm.nih.gov/pubmed/37686621
http://dx.doi.org/10.3390/cancers15174345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486942/
https://www.ncbi.nlm.nih.gov/pubmed/37686621
http://dx.doi.org/10.3390/cancers15174345

Ejemplares similares